Medtronic PLC/ IE00BTN1Y115 /
20/09/2024 22:10:00 | Chg. -0.13 | Volume | Bid10:38:44 | Ask10:38:44 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
89.34USD | -0.15% | 25.45 mill. Turnover: 1.36 bill. |
89.45Bid Size: 100 | 89.86Ask Size: 400 | 114.58 bill.USD | 3.09% | 32.25 |
GlobeNewswire
12/08
Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
12/08
SEALSQ is Leading the Charge in Helping Clients Transition from Digitalization to Robotization Setti...
GlobeNewswire
30/07
Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board o...
GlobeNewswire
09/07
Thurgood Marshall College Fund president focusing on engaging with high school students and member s...
GlobeNewswire
03/06
EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations
GlobeNewswire
02/06
NVIDIA Enables Real-Time Healthcare, Industrial and Scientific AI Applications at the Edge With Ente...
GlobeNewswire
13/05
Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
09/05
Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for im...
GlobeNewswire
30/04
Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Paten...
GlobeNewswire
23/04
Tactile Medical Announces CEO Transition and Preliminary First Quarter 2024 Revenue
GlobeNewswire
23/04
Blue Cross and Blue Shield of Minnesota Announces Chris Boles as Vice President of Medicare, Melissa...
GlobeNewswire
27/03
Increased Adoption of Artificial Intelligence Across the Healthcare Industry Driving Strong Market G...
GlobeNewswire
26/03
Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of D...
GlobeNewswire
13/03
Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy ...